New findings from Vanderbilt neurologists suggest that cardiovascular disease may increase the spaces surrounding blood vessels in the brain and lead to cognitive decline.
Vanderbilt’s Lucie Kalousová, PhD, and Corey Bolton, PsyD, have received research awards from the Alzheimer’s Association.
Detecting the neuropathology underlying cognitive impairment by lead to new targeted therapies.
Greater aortic stiffness is related to lower cerebral blood flow, especially among individuals with increased genetic predisposition to Alzheimer’s disease, according to research from Vanderbilt University Medical Center.
Vanderbilt University scientists have received notification from the U.S. Food and Drug Administration that testing in humans may proceed for an investigational new drug for Alzheimer’s disease after more than 10 years of research by scientists at Vanderbilt University and Vanderbilt University Medical Center.
Katherine Gifford, Psy.D., is testing simple questions to see which ones yield the most reliable results as she develops a questionnaire for primary care providers to quickly identify patients at risk for cognitive decline.
Accessibility Tools